Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

MD Anderson mentioned in IDEAS conference.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
a1derfullife Member Profile
 
Followed By 3
Posts 408
Boards Moderated 1
Alias Born 07/12/05
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/15/2021 12:36:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/22/2020 9:01:10 AM
Biotech Companies; Recent Milestones and Potential Upside InvestorsHub NewsWire - 12/22/2020 8:05:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/10/2020 6:03:50 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2020 12:47:44 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/16/2020 9:01:35 AM
Epazz, Inc. (OTC Pink: EPAZ) Adds Vaccine Management as part of COVID Compliance Features InvestorsHub NewsWire - 11/10/2020 6:48:57 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/2/2020 12:00:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/15/2020 10:02:03 AM
Annual Report (10-k) Edgar (US Regulatory) - 9/14/2020 4:51:25 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/4/2020 9:32:58 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2020 9:30:11 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/22/2020 10:01:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/20/2020 3:10:16 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/20/2020 6:03:30 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 7/15/2020 10:56:17 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 7/10/2020 5:09:32 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 7/10/2020 3:07:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2020 5:28:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/26/2020 2:16:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/21/2020 9:33:35 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2020 9:03:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/28/2020 9:30:58 AM
Cannabis and CBD Stocks are Old News, The Next Hot Peripheral Sector is Here! InvestorsHub NewsWire - 4/16/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/6/2020 2:21:58 PM
a1derfullife   Saturday, 05/18/13 01:33:41 AM
Re: None
Post # of 340428 
MD Anderson mentioned in IDEAS conference.

At 28:55 into the IDEAS conference, when Dr Menon was talking about their cash situation, he mentioned that most of the institutions they were working with were paying for the trials themselves, or were giving Cellceutix preferential treatment, rather than asking Cellceutix to pay the full cost of the trials. One of the examples he gave was MD Anderson, which I believe is the first time MD Anderson's name was specifically mentioned as a collaborating institution (although a number of posters on this board have speculated that they were negotiating a collaboration agreement with CTIX).

A1

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences